
GSK has announced data from its new global survey about shingles. The data suggests that there are some significant gaps …

GSK has announced that it has come to an exclusive agreement with Chingqing Zhifei Biological Products to co-promote GSK’s shingles …

GSK has announced positive results today from its first efficacy trial for Shingrix recombinant zoster vaccine (RZV) in China. These …

GSK’s shingles vaccine has secured approval in China, the company said, after the National Medical Products Administration (NMPA) authorised the …

GlaxoSmithKline has announced that its shingles vaccine Shingrix has secured approval in two new regions: in Europe, for the prevention …

GlaxoSmithKline has announced that its shingles vaccine Shingrix (Zoster Vaccine Recombinant, Adjuvanted) has been awarded FDA approval for the prevention …

The FDA’s advisory panel has given a strong signal that GSK’s Shingrix should not have too much difficulty getting full …

After filing for FDA approval in October, GlaxoSmithKline has now applied for approval from the European Commission (EC) for its …

GlaxoSmithKlien, the UK’s biggest drugmaker, is seeking approval from the FDA for a shingles (herpes zoster) vaccine. The vaccine would …

GlaxoSmithKline will be celebrating following the successful Phase III study of its shingles vaccine HZ/su that has met its primary …

Pfizer has reported positive Phase III results for a new formulation of its painkiller Lyrica. In the study, a controlled-release …

The NHS will introduce a nationwide shingles vaccination scheme this week aimed at people in their 70s. Merck’s Zostavax will …
GlaxoSmithKline has started enrollment for phase III trials for its herpes zoster vaccine for the prevention of shingles. The trials …
The government is to undertake what it calls “a rigorous procurement programme” to look for a suitable shingles vaccine. Possibilities …